A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors
- 31 March 1976
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 36 (1), 141-147
- https://doi.org/10.1016/0014-2999(76)90265-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Hypothalamic Releasing Factors and Parkinson DiseaseArchives of Neurology, 1974
- Effect of Melanocyte-Stimulating Hormone-Release Inhibiting Factor (MIF) in Parkinson’s SyndromEuropean Neurology, 1974
- L-Prolyl-L-leucyl-glycinamide (PLG): influences on locomotor and stereotyped behavior of catsBrain Research, 1973
- Effects of amantadine and 1-Dopa on apomorphine- and d-amphetamine-induced stereotyped behaviour in ratsEuropean Journal of Pharmacology, 1973
- Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: A possible mode of action in Parkinson's diseaseEuropean Journal of Pharmacology, 1971
- Isolation and structure of hypothalamic MSH release-inhibiting hormoneBiochemical and Biophysical Research Communications, 1971
- Mode of action of apomorphine and dexamphetamine on gnawing compulsion in ratsPsychopharmacology, 1967
- MSH activity in pituitaries of rats treated with hypothalamic extractsGeneral and Comparative Endocrinology, 1966
- Melanocyte-Stimulating Hormone (MSH) and ACTH Activities of Pituitary Homografts in Albino RatsEndocrinology, 1964
- Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatumLife Sciences, 1964